(Q35607638)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675260%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

review article

1 reference

title

Pathogenesis and management of alcoholic hepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675260%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675260%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

5

Geoffrey W McCaughan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675260%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Paul S Haber

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675260%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Ross Warner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675260%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Devanshi Seth

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675260%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675260%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology and Hepatology

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675260%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675260%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675260%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

1332-1344

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675260%20AND%20SRC:MED&resulttype=core&format=json

Red blood cell antioxidant and iron status in alcoholic and nonalcoholic cirrhosis.

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Molecular mechanisms of endotoxin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

The toll of innate immunity on microbial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Interleukin 6 and liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Beyond CAGE. A brief clinical approach after detection of substance abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Carbohydrate deficient transferrin in the assessment of alcohol misuse: absolute or relative measurements? A comparison of two methods with regard to total transferrin concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Pharmacological treatment of alcohol dependence: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Lack of hepatotoxicity with naltrexone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

The treatment of alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Mechanisms of alcoholic liver disease: cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X

Effect of liver cirrhosis on the systemic availability of naltrexone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.03217.X